Announcement on the Wholly-owned Subsidiary Obtaining the Approval Notice for Drug Supplementary Application

About this update from Shanghai Shyndec Pharmaceutical Co., Ltd. Class A

Announcement on the Wholly-owned Subsidiary Obtaining the Approval Notice for Drug Supplementary ApplicationThe abstract is for reference only. Please refer to the full text of the announcement on the very day.Link of Full Text for Reference: View Attachment

View stock analysis, news, and events for Shanghai Shyndec Pharmaceutical Co., Ltd. Class A